Rolf Turk, Ph.D., senior staff scientist at Integrated DNA Technologies guides readers through the future biomedical applications of CRISPR.
CRISPR
With clustered regularly interspaced short palindromic repeats (CRISPR) gene editing therapies entering Phase I clinical trials - some employing the high-fidelity Cas9 nuclease we devised at Integrated DNA Technologies (IDT) - it makes sense for us to look ahead and anticipate the needs of researchers developing new biomedical applications for CRISPR. Beyond the treatment of genetic diseases and genetic-related diseases, such as cancer, there are many other key applications of CRISPR being investigated. We will focus on three.
CRISPR-based kit enables simple and fast diagnosis at home
As we embark on the Fourth Industrial Revolution, computing is transforming virtually every facet of our lives, from the way we live and work, to how we communicate and relate to each other. A key characteristic of this revolution is the fusion of technologies that is blurring the lines between the physical, digital, and biological spheres.